INNOVATE (NYSE:VATE) Issues Quarterly Earnings Results

Key Points

• INNOVATE reported a significantly improved quarter: Revenue rose 74.2% year over year to $421.6 million, while adjusted EBITDA increased to $46.3 million and net income reached $10.4 million. The company also beat earnings expectations by $2.89 per share.
• Infrastructure led performance and strategic activity: DBMG revenue rose 77.6% to $414 million, adjusted backlog reached $2.7 billion, and INNOVATE refinanced its Broadcasting business while agreeing to sell CONX a 75% controlling stake, subject to regulatory approvals.
• Financial constraints remain a risk: Cash fell to $87.8 million, debt rose to $626.4 million, and R2 revenue declined 31.3% amid liquidity-related sales reductions. The stock fell 1.2% to $7.47, while analysts’ consensus rating remained “Sell.”

INNOVATE (NYSE:VATE - Get Free Report) released its quarterly earnings data on Thursday. The company reported $0.71 earnings per share for the quarter, beating analysts' consensus estimates of ($2.18) by $2.89, FiscalAI reports. The company had revenue of $421.60 million for the quarter, compared to analysts' expectations of $251.70 million.

Here are the key takeaways from INNOVATE's conference call:

• Q2 results improved substantially: Revenue rose 74.2% year over year to $421.6 million, Adjusted EBITDA increased to $46.3 million from $15.7 million, and net income attributable to stockholders reached $10.4 million versus a $22 million loss a year ago.
• Infrastructure delivered a record quarter, with DBMG revenue up 77.6% to $414 million and Adjusted EBITDA reaching $48.7 million. Adjusted backlog expanded to $2.7 billion, supported by demand from data centers, technology, healthcare, semiconductors, energy systems, and digital connectivity.
• INNOVATE refinanced Broadcasting with $105 million of financing and agreed to sell CONX a controlling 75% interest, while retaining 25% and an option to increase its stake to 40%. CONX also committed up to $75 million of post-closing equity capital, although closing remains subject to FCC and other regulatory approvals.
• MediBeacon reported continued progress in commercial placements and is engaging with more than 100 healthcare institutions, while pursuing reimbursement and regulatory initiatives. Its Lumitrace marketing authorization application in Europe is targeted for filing in 2027, indicating meaningful commercialization opportunities remain longer term.
• Liquidity and financing remain constraints in parts of the portfolio: consolidated cash declined to $87.8 million from $108.2 million at year-end, total debt rose to $626.4 million, and R2’s revenue fell 31.3% due partly to liquidity-related reductions in unit sales. R2 is seeking additional capital to fund inventory, manufacturing, and commercial expansion.

INNOVATE Trading Down 1.2%

NYSE:VATE traded down $0.09 during trading hours on Thursday, reaching $7.47. 141,326 shares of the company were exchanged, compared to its average volume of 98,044. The firm has a market cap of $101.93 million, a PE ratio of -1.76 and a beta of 2.35. INNOVATE has a twelve month low of $3.75 and a twelve month high of $21.30. The stock's 50-day moving average is $13.51 and its 200-day moving average is $9.77.

Analyst Upgrades and Downgrades

VATE has been the topic of several analyst reports. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of INNOVATE in a report on Monday, May 18th. Wall Street Zen raised INNOVATE to a "buy" rating in a report on Saturday, May 16th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Sell".

Institutional Trading of INNOVATE

Institutional investors and hedge funds have recently modified their holdings of the stock. Citadel Advisors LLC lifted its stake in shares of INNOVATE by 60.2% in the third quarter. Citadel Advisors LLC now owns 37,694 shares of the company's stock worth $184,000 after buying an additional 14,163 shares in the last quarter. Squarepoint Ops LLC purchased a new stake in INNOVATE during the 3rd quarter valued at about $58,000. Jane Street Group LLC acquired a new stake in INNOVATE in the 4th quarter valued at about $51,000. Finally, Bank of America Corp DE raised its holdings in INNOVATE by 13.4% in the 3rd quarter. Bank of America Corp DE now owns 18,962 shares of the company's stock valued at $93,000 after acquiring an additional 2,236 shares during the last quarter. Hedge funds and other institutional investors own 34.28% of the company's stock.

About INNOVATE

INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source